Table 1.
Demographic data and baseline characteristics
| ABP 980 (n = 50) | Trastuzumab (US) (n = 52) | Trastuzumab (EU) (n = 55) | |
|---|---|---|---|
| Mean age, years (SD) | 25.8 (5.8) | 25.4 (5.6) | 25.6 (4.6) |
| Mean weight, kg (SD) | 76.4 (11.1) | 73.6 (10.8) | 74.7 (11.8) |
| Mean height, cm (SD) | 176.5 (6.25) | 177.2 (7.37) | 177.6 (8.01) |
| Mean BMI, kg/m2 (SD) | 24.4 (2.8) | 23.3 (2.5) | 23.6 (3.4) |
| Race, n (%) | |||
| Asian (1st generation Japanese) | 10 (20.0) | 10 (19.2) | 11 (20.0) |
| Asian (other) | 8 (16.0) | 6 (11.5) | 5 (9.1) |
| Black or African-American | 3 (6.0) | 0 | 0 |
| White | 28 (56.0) | 34 (65.4) | 36 (65.5) |
| Other | 1 (2.0) | 2 (3.8) | 3 (5.5) |
BMI body mass index, SD standard deviation